Mavoglurant (AFQ056) for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease: a meta-analysis.

Ahmed NegidaHazem S GhaithSalma Yousry FalaHussien AhmedEshak I BahbahMahmoud Ahmed EbadaMohamed Abd Elalem Aziz

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)

This meta-analysis provides level one evidence that mavoglurant is not effective in treating the LID in patients with PD.

Keyphrases

systematic review
high glucose
meta analyses
diabetic rats
parkinson disease
randomized controlled trial
oxidative stress
drug induced
endothelial cells